Fri, August 26, 2022
Thu, August 25, 2022
Wed, August 24, 2022
Tue, August 23, 2022
Mon, August 22, 2022
Fri, August 19, 2022
Thu, August 18, 2022
Wed, August 17, 2022

Marc Goodman Maintained (AXSM) at Buy with Increased Target to $75 on, Aug 22nd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-75-on-aug-22nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Marc Goodman of SVB Leerink, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $50 to $75 on, Aug 22nd, 2022.

Marc has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 1 agrees with Marc's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $55 on, Wednesday, August 10th, 2022


These are the ratings of the 3 analyists that currently disagree with Marc


  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
  • Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $49 on, Tuesday, May 3rd, 2022

Publication Contributing Sources